Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PSYBF PsyBio Therapeutics to Present at the H.C. Wainwright Bioconnect Conference OXFORD, Ohio and COCONUT CREEK, Fla., Jan. 10, 2022 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focusing on discovering and developing new, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, today announced that Evan Levine, Chief Executive Officer and Chairman, will present at the H.C. Wainwright Bioconnect Conference.